[A case review: About a STEMI in the very elderly]. / Un cas, une revue: un SCA ST+ chez le sujet très âgé.
Ann Cardiol Angeiol (Paris)
; 64(6): 492-8, 2015 Dec.
Article
em Fr
| MEDLINE
| ID: mdl-26525681
Because of the demographic growth of our societies and the increasing prevalence of coronary artery disease with age, we will be increasingly faced with the treatment of myocardial ST+ very elderly patients (>90 years?). If evidence-based medicine does not exist within this framework, there are many registries that can guide us in their care. First, age should not in itself be an indication against reperfusion conventional techniques. In fact recommendations put no upper age limit. The primary angioplasty technical success, which is identical to the younger populations, is the treatment of choice and should be performed preferably by radial arterial access. The thrombolytic alternative, validated for octogenarians, has not been studied for older. Bleeding, neurological, ischemic complications and hospital mortality are more common than in younger populations, especially as the initial hemodynamic alteration is important, but the survivors have the same life-threatening or even better than that of a same reference population ages. Which in itself even justifies maximum adhesion to the therapeutic recommendations taking into account the co-morbidities and possible visceral shortcomings.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Ticlopidina
/
Envelhecimento
/
Inibidores da Agregação Plaquetária
/
Heparina
/
Angioplastia Coronária com Balão
/
Anti-Inflamatórios não Esteroides
/
Anticoagulantes
/
Infarto do Miocárdio
Tipo de estudo:
Diagnostic_studies
/
Guideline
/
Risk_factors_studies
Limite:
Aged80
/
Female
/
Humans
Idioma:
Fr
Revista:
Ann Cardiol Angeiol (Paris)
Ano de publicação:
2015
Tipo de documento:
Article